Poster presentation at SITC 2022 highlights high throughput methods for discovery of novel CAR designs with improved persistence BOSTON, Nov. 9, 2022 /PRNewswire/ -- Ginkgo Bioworks (DNA), the leading ...
Hosted on MSN
Enhanced CAR T cells emerge from genetic screening
CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...
Waypoint Bio has raised $14.5 million in seed funding to support its work pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results